2-Year U.S. Treasury Note Continuous Contract $101.523 0.000 0.00% 5-Year U.S. Treasury Note Continuous Contract $105.070 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $107.906 0.047 ...

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases.

46 % from last quarter Total Income of Rs 13,128.10 Crore and down 5.67 % from last year same quarter Total Income of Rs 13,981.70 Crore. Company has reported net profit after tax of Rs 518.96 Crore ...

Bonus Jul 19, 1991 Aug 21, 1991 Sep 30, 1991 Bonus Ratio: 1 share(s) for every 2 shares held Bonus--Jun 22, 1987 Bonus Ratio: 1 share(s) for every 1 shares held Bonus--Jun 22, 1983 Bonus Ratio: 3 ...